Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

Thiogenesis Therapeutics, Corp. (Q8M.F)

0.3840
-0.0260
(-6.34%)
At close: May 2 at 9:59:02 AM GMT+2
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
2/28/2022
12/31/2021
Operating Expense
4,388.5100
5,206.0210
1,974.8470
224.6780
1,279.0660
Operating Income
-4,388.5100
-5,206.0210
-1,974.8470
-224.6780
-1,279.0660
Net Non Operating Interest Income Expense
201.7200
171.1650
2.0580
0.2210
-3.0030
Other Income Expense
96.6480
-28.1550
-1,951.4620
--
63.8070
Pretax Income
-4,090.1420
-5,063.0110
-3,924.2510
-224.4570
-1,218.2620
Net Income Common Stockholders
-4,090.1420
-5,063.0110
-3,924.2510
-224.4570
-1,218.2620
Diluted NI Available to Com Stockholders
-4,090.1420
-5,063.0110
-3,924.2510
-224.4570
-1,218.2620
Total Expenses
4,388.5100
5,206.0210
1,974.8470
224.6780
1,279.0660
Net Income from Continuing & Discontinued Operation
-4,090.1420
-5,063.0110
-3,924.2510
-224.4570
-1,218.2620
Normalized Income
-4,186.7900
-5,034.8560
-3,980.4420
-224.4570
-1,282.0690
Interest Income
201.7200
171.1650
6.1810
0.2470
--
Interest Expense
--
--
4.1230
0.0260
3.0030
Net Interest Income
201.7200
171.1650
2.0580
0.2210
-3.0030
EBIT
-4,245.5000
-5,063.0110
-3,920.1280
-224.4310
-1,215.2590
EBITDA
-4,245.5000
-5,063.0110
-3,920.1280
-224.4310
-1,215.2590
Net Income from Continuing Operation Net Minority Interest
-4,090.1420
-5,063.0110
-3,924.2510
-224.4570
-1,218.2620
Total Unusual Items Excluding Goodwill
96.6480
-28.1550
56.1910
--
63.8070
Total Unusual Items
96.6480
-28.1550
56.1910
--
63.8070
Normalized EBITDA
-4,342.1480
-5,034.8560
-3,976.3190
-224.4310
-1,279.0660
12/31/2021 - 2/24/2025

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

NEUP Neuphoria Therapeutics Inc.
5.06
+1.10%
 
PMVP PMV Pharmaceuticals, Inc.
0.9966
-0.34%
 
EPIX ESSA Pharma Inc.
1.7300
-2.26%
 
IKNA Ikena Oncology, Inc.
1.2500
+2.46%
 
HLVX HilleVax, Inc.
1.9600
+1.55%
 
ATXS Astria Therapeutics, Inc.
5.36
+3.88%
 
KZR Kezar Life Sciences, Inc.
4.5000
+2.27%
 
GLTO Galecto, Inc.
2.9900
-1.64%
 
NERV Minerva Neurosciences, Inc.
1.7000
-2.30%
 
ANTX AN2 Therapeutics, Inc.
1.2200
-1.61%